Related Experiment Video

Updated: Jun 8, 2026

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in

Yair Herishanu1, Patricia Pérez-Galán, Delong Liu

  • 1National Heart, Lung and Blood Institute, National Institutes of Health , Bethesda, MD, USA.

Blood
|October 14, 2010
PubMed

Insights

The lymph node microenvironment fuels chronic lymphocytic leukemia (CLL) progression by activating B-cell receptor signaling. Targeting these interactions may offer new therapeutic strategies for CLL patients.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Chronic lymphocytic leukemia (CLL) is an incurable B-cell malignancy where the tumor microenvironment's role in vivo is unclear.
  • Understanding tumor-host interactions is crucial for elucidating CLL pathogenesis.

Purpose of the Study:

  • To investigate the in vivo effects of tumor-host interactions on CLL pathogenesis.
  • To identify key sites and molecular pathways driving CLL progression.

Main Methods:

  • Gene expression profiling of CLL cells from blood, bone marrow, and lymph nodes of 24 treatment-naive patients.
  • Analysis of B-cell receptor (BCR) and nuclear factor-κB (NF-κB) signaling pathways.
  • Quantification of tumor proliferation using gene expression and Ki67 staining.

Main Results:

  • Lymph nodes (LN) are identified as a key site for CLL pathogenesis.
  • CLL cells in LN exhibit activated BCR and NF-κB signaling, with stronger BCR target gene expression in aggressive disease.
  • Tumor proliferation is highest in LN and correlates with clinical disease progression.

Conclusions:

  • The lymph node microenvironment significantly contributes to CLL pathogenesis through BCR signaling.
  • Disrupting tumor microenvironment interactions and inhibiting BCR signaling are potential therapeutic strategies for CLL.

More Related Videos

Modeling Chemotherapy Resistant Leukemia In Vitro08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...